Yuchuan Gong
About Yuchuan Gong
Yuchuan Gong is the Vice President, Head of Small Molecule CMC at BeiGene in New Jersey, with extensive experience in formulation development and a strong background in physical chemistry and chemical engineering.
Company
Yuchuan Gong is currently working at BeiGene as the Vice President, Head of Small Molecule CMC, located in New Jersey, United States. BeiGene is a global biotechnology company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer.
Title
Yuchuan Gong holds the position of Vice President, Head of Small Molecule CMC at BeiGene. His role involves oversight of the chemical, manufacturing, and control (CMC) processes specifically for small molecule therapies, which are a critical aspect of the pharmaceutical development pipeline.
Industry Experience
Yuchuan Gong has accumulated extensive experience in the pharmaceutical industry. Notably, he worked at Bristol-Myers Squibb as a Director from 2019 to 2021 and at Celgene as Director of Formulation Development from 2018 to 2019, both based in Summit, New Jersey. Prior to these roles, he spent five years at AbbVie Inc in the Greater Chicago Area as Principal Scientist/Section Manager for Formulation Sciences/Operations and another five years at Abbott Laboratories as Research Investigator/Group Leader for NCE Formulation Sciences.
Academic and Early Career Background
Yuchuan Gong's academic career includes roles such as Research Assistant Professor at the University of Minnesota from 2004 to 2006 and Postdoctorate Associate at the University of Puerto Rico from 2002 to 2004. He holds a Ph.D. in Physical Chemistry from the University of Puerto Rico and a B.S. in Chemical Engineering from Southeast University. Additionally, he earned an MBA from The University of Chicago Booth School of Business, focusing on Finance, Entrepreneurship, Strategic Management, and General Management.
Leadership in Pharmaceutical Development
Throughout his career, Yuchuan Gong has held multiple leadership roles in pharmaceutical development. He was a Principal Scientist and Section Manager at AbbVie Inc and a Director at both Bristol-Myers Squibb and Celgene. His expertise in formulation development and CMC processes have been essential in these positions, driving forward the development of pharmaceutical products in various environments.